Last updated: January 4, 2025
Introduction to NDC 69809-0126
The National Drug Code (NDC) 69809-0126 corresponds to CLOZARIL, a brand name for the drug clozapine, which is used in the treatment of schizophrenia and other severe mental health conditions. Here, we will delve into the market analysis and price projections for this specific drug.
Drug Overview
CLOZARIL (Clozapine)
- Packager: HLS Therapeutics (USA), Inc.[5]
- Marketing Status: Approved under a New Drug Application (NDA) since 1989[5]
- DEA Schedule: None[5]
- Usage: Oral tablets for the treatment of schizophrenia and other severe mental health conditions.
Market Trends in the Pharmaceutical Industry
The pharmaceutical industry, particularly the segment involving prescription drugs, is subject to various market trends that influence pricing and demand.
Global Market Size and Growth
The biopharma and biotech industries are experiencing significant growth, with the biopharma market estimated to be over $400 billion in 2024 and projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].
Price Trends in the U.S. and Global Markets
Drug prices in the U.S. are notably higher compared to other regions. In 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as in the rest of the world (excluding the U.S.)[4].
Pricing and Cost Analysis for NDC 69809-0126
Current Pricing
As of the latest data, specific pricing for CLOZARIL (NDC 69809-0126) is not readily available in the sources provided. However, we can infer pricing trends from similar drugs and market analyses.
Price Projections
Given the general trend in the pharmaceutical industry, here are some key points to consider for price projections:
- General Price Increase: The pharmaceutical industry is expected to see a general increase in drug prices, with a projected 3.8% increase in 2024[2].
- Market Dynamics: The U.S. market has seen an average price increase of 14% between 2017 and 2022, which is significantly higher than the decreases observed in other regions[4].
Factors Influencing Pricing
Regulatory Environment
Changes in regulatory frameworks can significantly impact drug pricing. For instance, evolving clinical trial designs and regulatory landscapes are expected to shape the future of drug development and pricing in 2025[3].
Technological Advancements
Technological innovations, such as accelerated clinical trial designs and the use of AI/ML technologies, can influence the efficiency and cost of drug development, potentially affecting final product prices[3].
Market Competition
The presence of generic or biosimilar alternatives can impact the pricing of branded drugs like CLOZARIL. However, since clozapine is a unique medication with limited generic competition, its pricing may remain relatively stable or increase in line with industry trends.
Market Size and Sales Revenue
U.S. vs. Global Markets
The U.S. market for prescription drugs, including biologic products, has seen significant growth. For biologic products, U.S. sales revenues grew by 61% in recent years, contrasting with contractions in other regions[4].
Retail vs. Non-Retail Markets
Sales revenues in the U.S. grew similarly in both retail and non-retail markets, with 22% and 26% growth respectively, while other regions saw declines in retail markets but growth in non-retail markets[4].
NDC Directory and Drug Information
The FDA's New NDC Directory provides comprehensive information on drugs, including their NDC numbers, proprietary names, active ingredients, and marketing dates. For CLOZARIL, this directory would list details such as the product type, dosage form, route of administration, and marketing dates[1].
Key Takeaways
- Market Growth: The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements and evolving regulatory frameworks.
- Price Trends: Drug prices in the U.S. are significantly higher than in other regions and are expected to continue increasing.
- Regulatory Impact: Changes in regulatory environments and clinical trial designs can influence drug pricing and development.
- Technological Innovations: AI/ML technologies and precision medicine are expected to shape the future of pharmaceutical research and pricing.
- Market Competition: The pricing of CLOZARIL may remain relatively stable due to its unique status and limited generic competition.
FAQs
1. What is the NDC code for CLOZARIL?
The NDC code for CLOZARIL is 69809-0126.
2. What is CLOZARIL used for?
CLOZARIL (clozapine) is used in the treatment of schizophrenia and other severe mental health conditions.
3. How do U.S. drug prices compare to global prices?
U.S. drug prices are significantly higher, with the average price per unit in the U.S. being 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as in the rest of the world (excluding the U.S.)[4].
4. What are the projected price increases for drugs in 2024?
A general increase of 3.8% in drug prices is projected for 2024[2].
5. How do technological advancements impact drug pricing?
Technological innovations, such as AI/ML technologies and precision medicine, can influence the efficiency and cost of drug development, potentially affecting final product prices[3].
Sources
- YouTube - NDC Directory: "NDC Directory" (March 2015)
- DrugPatentWatch: "Latest drug prices and trends for NDC 62756-0301" (January 2025)
- TFS CRO: "5 Predictions for the Biopharma and Biotech Industries in 2025" (November 2024)
- ASPE: "International Market Size and Prices" (December 2024)
- DailyMed: "Label: CLOZARIL- clozapine tablet" (November 2024)
